Articles

All male patients with low testosterone levels are at a higher risk for cardiovascular disease, especially those with type 2 diabetes mellitus.  

A new study reveals that bimagrumab can have metabolic improvement for those suffering from obesity and type 2 diabetes. 

Mitochondrial function is crucial for maintaining cellular metabolism and growth and plays a role in some forms of diabetes. Diabetes mellitus causes much morbidity and mortality for Americans and people worldwide. In addition, it significantly reduces the quality of life and life span of patients that have diabetes. Mitochondrial dysfunction …

Data analysis reveals that intermittent fasting has positive health outcomes ranging from weight loss to elimination of metabolic stress. 

Dapagliflozin (Farxiga®) has been granted U.S. Food and Drug Administration (FDA)  Breakthrough Therapy Designation (BTD) for patients with chronic kidney disease (CKD), whether or not they have type 2 diabetes. 

Should current guidelines lower the blood pressure treatment threshold for increased prevention of CVD?

Addressing the gaps in lipoprotein cholesterol (LDL-C) control and statin prescribing among patients with type 2 diabetes.

No differences in the barriers to weight loss and weight loss success were observed between the intermittent (IER) and continuous (CER) dieters.

In addition to clinical trials, does data from a meta-analysis of retrospective cohort studies support the benefits of SGLT-2 inhibitors?

Can we reduce mortality with patients with Covid-19 by controlling blood glucose?